http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10629413

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 1478-6354
1478-6362
issueIdentifier 4
pageRange R113-
publicationName Arthritis Research & Therapy
startingPage R113
bibliographicCitation Moran EM, Mullan R, McCormick J, Connolly M, Sullivan O, Fitzgerald O, Bresnihan B, Veale DJ, Fearon U. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther. 2009;11(4):R113. PMID: 19627579; PMCID: PMC2745795.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c63313ac3518f3599d11bd939acad6b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6607-6070
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65cb437494657e61aa1567c0ae173727
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f93556db17473e0b6e786f60a9dc3c5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8084-0429
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ed5f756f227cb21366475a66824c9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9509e293ce0a2b4f74eb90d5344dde2c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe6f1d995cb061fe5940e2308d4f19f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3d11a19049c8f3afe093c8050e63192
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_331952401ad657f5362f952be858ebdf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fcc8b3892f7208798b2324d26394819
date 2009-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19627579
https://pubmed.ncbi.nlm.nih.gov/PMC2745795
https://doi.org/10.1186/ar2772
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30289
https://portal.issn.org/resource/ISSN/1478-6354
https://portal.issn.org/resource/ISSN/1478-6362
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies
discusses http://id.nlm.nih.gov/mesh/M0030025
http://id.nlm.nih.gov/mesh/M0022150
http://id.nlm.nih.gov/mesh/M0328197
http://id.nlm.nih.gov/mesh/M0027742
http://id.nlm.nih.gov/mesh/M0145692
http://id.nlm.nih.gov/mesh/M0029271
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f689a8c7a6c83057b4b10a0ff8397d2d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a6f249d97ff4e63d73c5bcba782d885
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b675bc7335b70898bce59b335124e924
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0754cc4816e7827d933c426990d9fdc8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f7897891f9d912ba3656f4d7e0e9fad
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_06ba0e5875c2168be8c3f6622e4f841b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8722
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8cb7e80809cc72f74cddd6d498451b46
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723800

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128376954
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128288165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129071275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128107971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135985134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127669892

Total number of triples: 58.